Targeted Therapies Redefined: Global Gene Silencing Market Insights
Executive Summary The global gene silencing market is undergoing rapid expansion, propelled by advancements in RNA interference (RNAi), CRISPR-Cas9, and antisense oligonucleotides (ASOs). Valued at approximately USD 3.7 billion in 2024, the market is projected to grow at a CAGR of 17.6%, reaching over USD 15.9 billion by 2032. This growth is driven by the increasing prevalence of genetic disorders, cancer, and neurodegenerative diseases, coupled with the rising adoption of gene-silencing technologies in therapeutics and drug discovery. Request Sample Report PDF (including TOC, Graphs & Tables): https://www.statsandresearch.com/request-sample/40640-global-gene-silencing-market Gene Silencing Market Overview Market Size and Growth The gene silencing market is experiencing significant growth Technological Advancements : Innovations in gene-editing tools and delivery systems. Rising Disease Prevalence : Increased cases of genetic disorders an...